LAM Therapeutics Scores $58 Million and a New Clinical Program in Cancer Post author:Sam Post published:March 29, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like SI-BONE Announces Published Guidance Recommendation For Minimally Invasive SI Joint Fusion From The SI-BONE April 6, 2017 Heads Up Tesaro: AstraZeneca PLC, Merck & Co.'s Ovarian Cancer Drug Just Got Expanded Use From the FDA August 17, 2017 OrbiMed Comments On Immunomedics Proxy Contest February 2, 2017
SI-BONE Announces Published Guidance Recommendation For Minimally Invasive SI Joint Fusion From The SI-BONE April 6, 2017
Heads Up Tesaro: AstraZeneca PLC, Merck & Co.'s Ovarian Cancer Drug Just Got Expanded Use From the FDA August 17, 2017